Immune health supplements are important for management of certain chronic conditions such as diabetes, obesity, constipation, malabsorption, and indigestion. It also helps to maintain healthy lifestyle, improve appetite and food intake, lower the risk of nutrient deficiencies, and other health conditions. Immune health supplements are recommended for patients of all ages including infants, adults, and geriatrics, who are susceptible to conditions such as diabetes, obesity, renal failures, chronic diseases, neurological diseases, and others. These factors have led to an increase in demand for immune health supplements.
The global immune health supplement market is estimated to be valued at US$ 15,441.9 million in 2020 and is expected to exhibit a CAGR of 7.1% during the forecast period (2020-2027).
Figure 1.Global Immune Health Supplement Market Share (%) in Terms of Value, By Ingredients 2020
Launch of immune health supplement products is expected to drive the market growth during the forecast period.
Launch of various immune health supplement products is expected to drive the global immune health supplement market growth over the forecast period. For instance, in March 2020, Conagen Inc., a biotechnology company, announced that it has developed a sustainable proprietary, lactoferrin protein that mirrors the nutritional properties of lactoferrin from breast milk.
Figure 2.Global Immune Health Supplement Market Share (%), By Source, 2020
Increasing prevalence of chronic diseases and other disorders in geriatric patients is expected to drive the global immune health supplement market growth during the forecast period.
The immune health supplements market is expected to witness significant growth during the forecast period, owing to the increasing prevalence of chronic diseases and other disorders among the geriatric population. For instance, according to the World Health Organization’s report from September 2019, around 50 million people across the globe have dementia and there are nearly 10 million new cases every year. As per the same source, Alzheimer’s disease is the most common form of dementia and may contribute to 60–70% of the overall cases.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2019 | Market Size in 2020: | US$ 15,441.9 Mn |
| Historical Data for: | 2016 to 2019 | Forecast Period: | 2020 to 2027 |
| Forecast Period 2020 to 2027 CAGR: | 7.1% | 2027 Value Projection: | US$ 24,951.0 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Abbott Nutrition, Bayer AG, Glanbia, Plc., EuroPharma, Inc., Bio Tech Pharmacal, Vital Nutrients, Herbalife Nutrition Ltd, Vitabiotics Ltd., NutriGold Inc., BioGaia, Natural Immunogenics, and Nutramax Laboratories |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Global Immune Health Supplement Market– Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization declared it as a public health emergency in March 2020. According to the World Health Organization’s report, the manifestation of coronavirus (COVID-19) has resulted in more than 153 million infected individuals worldwide as of May 4, 2021.
COVID-19 pandemic has affected the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, UAE, Egypt, and others are facing problems with regards to transportation of products from one place to another.
Furthermore, players operating in the global immune health supplement market are facing major challenges on various fronts due to the COVID-19 pandemic. The major challenges include the supply of raw materials required for manufacturing immune health supplement due to irregularities in transportation. Moreover, distributors are experiencing irregular demand for products from the retailers due to an increase in the number of patients suffering from COVID-19 and other life threatening disorders.
Global Immune Health Supplement Market: Restraint
The major factors that hinder growth of the global immune health supplement market include side effects and high cost of immune health supplement products and lack of awareness regarding nutritional diet among low- and middle-income countries. There is an inadequate level awareness about nutritional products and diseases associated with nutritional deficiencies in rural areas of low- and middle-income economies in Africa and Asia Pacific region. This is expected to result in slow adoption of medical nutritional products in these regions and thereby hinder the market growth.
Key Players
Major players operating in the global immune health supplement market are Abbott Nutrition, Bayer AG, Glanbia, Plc., EuroPharma, Inc., Bio Tech Pharmacal, Vital Nutrients, Herbalife Nutrition Ltd, Vitabiotics Ltd., NutriGold Inc., BioGaia, Natural Immunogenics, and Nutramax Laboratories
Immune health supplements play a major role in advance healthcare by supporting healthy aging and preventing malnutrition and vitamin deficiencies. Immune health supplement products consist of vitamins, proteins, minerals, lipids, fibers, and other essential substances that regulate the body functions and improve immunity. Immune health has become a major part of people’s lifestyle, as consumers are increasingly concerned about their health nowadays. There are various immune health supplement such as vitamin A, vitamin B2, vitamin B6, and vitamin C, which are used to increase immunity. Vitamin D is a fat-soluble nutrient essential to the health and functioning of immune system.
Market Dynamics
Key players operating in the global immune health supplement market are focusing on adoption of inorganic growth strategies such as acquisitions and collaborations, these factors are expected to drive the market growth during the forecast period. For instance, in June 2020, Nestlé Health Science, a subsidiary of Nestlé S.A., agreed to acquire a majority stake in Vital Proteins, a leading lifestyle and wellness platform offering supplements, beverages, and food products. The two companies signed their respective agreements on June 10, 2020, for the partial acquisition, which is subjected to customary regulatory approval. Furthermore In November 2018, Entrinsic Health Solutions (EHS), an innovative health sciences company, entered into a collaborative partnership with Nestlé Health Science, for commercialization of Enterade, a liquid beverage containing amino acid. Moreover, In January 2018, Nestlé entered into collaborative agreement with Biosearch Life in order to gain global marketing rights of breast milk probiotic strain Lactobacillus fermentum LC40 strain in food supplements aimed at breastfeeding women for promoting healthy lactation.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients